(Total Views: 511)
Posted On: 04/08/2020 12:13:34 PM
Post# of 154074
“So those previously enrolled are still receiving treatment (hopefully).
At my clinic we have transitioned to mostly telehealth, but continue to treat patients in the clinic who require regular monitoring, physical exams, certain injectable medications, etc. (essential treatments). I’m not in oncology, but I consider a cancer treatment as essential, so I have zero doubt that patients already enrolled in the trial are continuing to be treated.
I’m unsure how enrollment of new patients is regarded, especially considering some are on medications that comprise their immune system.
The one bonus right now is that CYDY has months and weeks of data on at least 10+ patients for cancer (maybe more) that hasn’t been released. The next update will not simply be, “...after 2 weeks of treatment, CTCs lowered,” but more robust and cite numerous months of suppressed CTCs and reduced tumor sizes. That’s very exciting.
At my clinic we have transitioned to mostly telehealth, but continue to treat patients in the clinic who require regular monitoring, physical exams, certain injectable medications, etc. (essential treatments). I’m not in oncology, but I consider a cancer treatment as essential, so I have zero doubt that patients already enrolled in the trial are continuing to be treated.
I’m unsure how enrollment of new patients is regarded, especially considering some are on medications that comprise their immune system.
The one bonus right now is that CYDY has months and weeks of data on at least 10+ patients for cancer (maybe more) that hasn’t been released. The next update will not simply be, “...after 2 weeks of treatment, CTCs lowered,” but more robust and cite numerous months of suppressed CTCs and reduced tumor sizes. That’s very exciting.
(2)
(0)
